Skip to main content

Showing 1 match for the following: Inventor: "Chen, Ming" ×

Using oxidative cell death to target RB1-deficient prostate cancer

Using oxidative cell death to target RB1-deficient prostate cancer

Unmet Need In the first quarter of 2023, there were approximately 288,300 Americans diagnosed with prostate cancer, accounting for about 15% of all new cancer diagnoses. The five-year survival rate of patients with prostate cancer…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us